These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 34219578)

  • 1. Erlotinib complexation with randomly methylated
    Erdoğar N; Akkın S; Varan G; Bilensoy E
    Pharm Dev Technol; 2021 Sep; 26(7):797-806. PubMed ID: 34219578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inclusion complex of erlotinib with sulfobutyl ether-β-cyclodextrin: Preparation, characterization, in silico, in vitro and in vivo evaluation.
    Devasari N; Dora CP; Singh C; Paidi SR; Kumar V; Sobhia ME; Suresh S
    Carbohydr Polym; 2015 Dec; 134():547-56. PubMed ID: 26428157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of Oral Tablet Formulation Containing Erlotinib: Randomly Methylated-β-cyclodextrin Inclusion Complex Using Direct Compression Method.
    Erdoğar N
    Turk J Pharm Sci; 2021 Oct; 18(5):589-596. PubMed ID: 34719186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential of erlotinib cyclodextrin nanosponge complex to enhance solubility, dissolution rate, in vitro cytotoxicity and oral bioavailability.
    Dora CP; Trotta F; Kushwah V; Devasari N; Singh C; Suresh S; Jain S
    Carbohydr Polym; 2016 Feb; 137():339-349. PubMed ID: 26686138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved oral bioavailability and therapeutic efficacy of erlotinib through molecular complexation with phospholipid.
    Dora CP; Kushwah V; Katiyar SS; Kumar P; Pillay V; Suresh S; Jain S
    Int J Pharm; 2017 Dec; 534(1-2):1-13. PubMed ID: 28970115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Erlotinib entrapped in cholesterol-depleting cyclodextrin nanoparticles shows improved antitumoral efficacy in 3D spheroid tumors of the lung and the liver.
    Varan G; Akkın S; Demirtürk N; Benito JM; Bilensoy E
    J Drug Target; 2021 Apr; 29(4):439-453. PubMed ID: 33210947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Erlotinib-Valproic Acid Liquisolid Formulation: Evaluating Oral Bioavailability and Cytotoxicity in Erlotinib-Resistant Non-small Cell Lung Cancer Cells.
    Patel K; Doddapaneni R; Patki M; Sekar V; Bagde A; Singh M
    AAPS PharmSciTech; 2019 Mar; 20(3):135. PubMed ID: 30830506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PEGylated polypeptide lipid nanocapsules to enhance the anticancer efficacy of erlotinib in non-small cell lung cancer.
    Kim J; Ramasamy T; Choi JY; Kim ST; Youn YS; Choi HG; Yong CS; Kim JO
    Colloids Surf B Biointerfaces; 2017 Feb; 150():393-401. PubMed ID: 27825759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paclitaxel and Erlotinib-co-loaded Solid Lipid Core Nanocapsules: Assessment of Physicochemical Characteristics and Cytotoxicity in Non-small Cell Lung Cancer.
    Gupta B; Poudel BK; Regmi S; Pathak S; Ruttala HB; Gautam M; An GJ; Jeong JH; Choi HG; Yong CS; Kim JO
    Pharm Res; 2018 Mar; 35(5):96. PubMed ID: 29536182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative analysis of zaleplon complexation with cyclodextrins and hydrophilic polymers in solution and in solid state.
    Jablan J; Szalontai G; Jug M
    J Pharm Biomed Anal; 2012 Dec; 71():35-44. PubMed ID: 22898722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclodextrin Complexation Improves the Solubility and Caco-2 Permeability of Chrysin.
    Fenyvesi F; Nguyen TLP; Haimhoffer Á; Rusznyák Á; Vasvári G; Bácskay I; Vecsernyés M; Ignat SR; Dinescu S; Costache M; Ciceu A; Hermenean A; Váradi J
    Materials (Basel); 2020 Aug; 13(16):. PubMed ID: 32824341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomly methylated β-cyclodextrin improves water - solubility, cellular protection and mucosa permeability of idebenone.
    De Gaetano F; Mannino D; Celesti C; Bulzomí M; Iraci N; Vincenzo Giofrè S; Esposito E; Paterniti I; Anna Ventura C
    Int J Pharm; 2024 Nov; 665():124718. PubMed ID: 39288841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of inclusion complexation between fenoxaprop-p-ethyl and cyclodextrin.
    Zhang A; Liu W; Wang L; Wen Y
    J Agric Food Chem; 2005 Sep; 53(18):7193-7. PubMed ID: 16131129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intestinal Permeability of β-Lapachone and Its Cyclodextrin Complexes and Physical Mixtures.
    Mangas-Sanjuan V; Gutiérrez-Nieto J; Echezarreta-López M; González-Álvarez I; González-Álvarez M; Casabó VG; Bermejo M; Landin M
    Eur J Drug Metab Pharmacokinet; 2016 Dec; 41(6):795-806. PubMed ID: 26602766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation and characterization of simvastatin/hydroxypropyl-beta-cyclodextrin inclusion complex using supercritical antisolvent (SAS) process.
    Jun SW; Kim MS; Kim JS; Park HJ; Lee S; Woo JS; Hwang SJ
    Eur J Pharm Biopharm; 2007 Jun; 66(3):413-21. PubMed ID: 17240129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclodextrin inclusion complex of racecadotril: effect of drug-β- cyclodextrin ratio and the method of complexation.
    Semalty M; Panchpuri M; Singh D; Semalty A
    Curr Drug Discov Technol; 2014 Jun; 11(2):154-61. PubMed ID: 24188445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physical properties and biological activities of hesperetin and naringenin in complex with methylated β-cyclodextrin.
    Sangpheak W; Kicuntod J; Schuster R; Rungrotmongkol T; Wolschann P; Kungwan N; Viernstein H; Mueller M; Pongsawasdi P
    Beilstein J Org Chem; 2015; 11():2763-73. PubMed ID: 26877798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclodextrin modified erlotinib loaded PLGA nanoparticles for improved therapeutic efficacy against non-small cell lung cancer.
    Vaidya B; Parvathaneni V; Kulkarni NS; Shukla SK; Damon JK; Sarode A; Kanabar D; Garcia JV; Mitragotri S; Muth A; Gupta V
    Int J Biol Macromol; 2019 Feb; 122():338-347. PubMed ID: 30401652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanosuspensions Containing Oridonin/HP-β-Cyclodextrin Inclusion Complexes for Oral Bioavailability Enhancement via Improved Dissolution and Permeability.
    Zhang X; Zhang T; Lan Y; Wu B; Shi Z
    AAPS PharmSciTech; 2016 Apr; 17(2):400-8. PubMed ID: 26187778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fosinopril-cyclodextrin inclusion complexes: phase solubility and physicochemical analysis.
    Sbârcea L; Udrescu L; Drăgan L; Trandafirescu C; Szabadai Z; Bojiţă M
    Pharmazie; 2011 Aug; 66(8):584-9. PubMed ID: 21901980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.